3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
2
Dermatologic
2
Plasma cell
1
Lymphoid
1
Genitourinary
1
Breast
1
Conditions
Sarcoma
1
Multiple Myeloma
1
Melanoma
1
Lymphoma
1
Kidney Neoplasms
1
Breast Neoplasms
1
Interventions
selinexor
2
pazopanib
2
Radiotherapy
2
Injections
2
Ifosfamide
2
Filgrastim
2
Doxorubicin
2
Cyclophosphamide
2
sargramostim
1
resiquimod
1
repotrectinib
1
poly ICLC
1
interferon-alfa-1b
1
cc-486
1
aldesleukin
1
Voriconazole
1
Thalidomide
1
Suspensions
1
Rituximab
1
Radiation
1
Quality of Life
1
Proton Therapy
1
Peripheral Blood Stem Cell Transplantation
1
Pentetic Acid
1
Patient Reported Outcome Measures
1
Molecular Diagnostic Techniques
1
Minocycline
1
Methotrexate
1
Melphalan
1
Magnetic Resonance Spectroscopy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Sarcoma
×
Interferons
×
Plasma cell
×
Clear all
NCT00276536
2015-10-14
IFNa
The Cleveland Clinic
Phase 1
Completed
35 enrolled